Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$556,124
+$110,487 QoQ
Shares Held
2,210
+7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#3,065
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Silver Coast Investments LLC holds $2,073,393 across 4 Drug Manufacturers - General names. ABBV ranks #2 (26.8% of the industry book) .
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $556,124 | 2,210 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $445,637 | 2,049 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $430,475 | 1,884 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $449,650 | 1,942 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $425,812 | 2,294 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $398,088 | 1,900 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $399,469 | 2,248 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $435,640 | 2,206 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $406,159 | 2,368 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $332,878 | 1,828 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $292,738 | 1,889 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||